NASDAQ:IART

Integra LifeSciences Holdings Corporation Earning Date

USA |NASDAQ |USD

IART Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2021 Sep 2021 $0.72 $0.79 $0.80
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2021 Sep 2021 $384.58M $389.99M $370.23M

Integra Lifesciences Holdings Corporation's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 2021.

IART Earnings Date & History Chart

IART Earnings & Revenue Forecast

IART Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 13 $0.81 $0.79 $0.83
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 14 $3.02 $2.98 $3.04
Dec 2022 14 $3.42 $3.23 $3.80

IART Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.81 $0.81 $0.82
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $3.02 $3.02 $2.92
Dec 2022 0 / 0 $3.42 $3.43 $3.36

IART Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 12 $409.65M $406.00M $412.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 13 $1.54B $1.54B $1.55B
Dec 2022 13 $1.64B $1.61B $1.74B

IART Earnings Date & Revenue History

IART Earnings History

|
Show More
Show More

IART Revenue History

|
Show More
Show More

Integra Lifesciences Holdings Corporation Next Earnings Date & Report

IART Next Earnings Date & Report Preview: Sep 2021 (FQ)

IART's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 13 analysts, the average EPS estimation for Integra Lifesciences Holdings Corporation's next quarterly earnings is $0.72, with a low EPS estimation of $0.71, and a high estimation of $0.74.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.73, the last 2 month trend is $0.73, and the 3 month trend is $0.74.

Based on 12 analysts, the average revenue estimation is $384.58M, with a low revenue estimation of $379.80M, and a high estimation of $388.20M.

Integra Lifesciences Holdings Corporation Previous Earnings Dates & Reports

IART Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Integra Lifesciences Holdings Corporation's previous earnings date was Jul 28, 2021 for its fiscal quarter ended Jun 30, 2021.

IART's earnings per share (EPS) was $0.79, beating the consensus analysts forecast of $0.66 by 19.84%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 14.49%, and higher than the same period a year before (Jun 2020) by 139.39%.

Revenues were $389.99M, better than the forecast of $376.01M by 3.72%, up by 8.31% from the previous quarter , and up by 50.77% from the same period last year.

The company reported a net income of $35.07M.

Free cash flow for the quarter was $84.66M , compared to $62.41M last quarter and $25.90M a year before.

IART ended the quarter with $1.65B in total debt, a decrease of -5.56% compared to the previous quarter, and an increase of 6.48% compared to the same quarter a year before.

IART Previous Earnings Date & Report Recap: Dec 2020 (FY)

Integra Lifesciences Holdings Corporation's previous annual earnings date was Feb 18, 2021 for its fiscal year ended Dec 31, 2020.

IART's earnings per share (EPS) was $2.45, beating the consensus analysts forecast of $2.33 by 5.15% , and lower than the previous year's EPS (Dec 2019) by -10.58%.

Revenues were $1.37B, better than the forecast of $1.37B by 0.25%, and down by -9.60% from previous year's revenue.

The company reported a net income of $133.89M, 166.71% higher than the previous year.

Integra Lifesciences Holdings Corporation reported a free cash flow of $139.94M for its fiscal year, compared to $96.90M a year ago.

The company ended the fiscal year with $1.57B in total debt, an increase of 15.22% compared to the previous year.